Fanny Cavalié
Geschäftsführer bei FOGHORN THERAPEUTICS INC.
Vermögen: 443 033 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Fanny Cavalié
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
100
| Public Company | Pharmaceuticals: Major | 100 |
École des Hautes Études Commerciales de Paris
67
| College/University | Other Consumer Services | 67 |
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU.
39
| Subsidiary | Investment Managers | 39 |
Public Company | Biotechnology | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fanny Cavalié
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO General Counsel | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Founder | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Corporate Officer/Principal | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Doctorate Degree | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Comptroller/Controller/Auditor | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
University of Massachusetts | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree Undergraduate Degree | |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
ZAI LAB LIMITED | Biotechnology | Director/Board Member General Counsel | |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member Director/Board Member | |
Ardian SA
Ardian SA Investment ManagersFinance Ardian SA (Ardian) is a private equity subsidiary of Ardian Holding SAS founded in 1995. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
MODERNA, INC. | Biotechnology | Founder General Counsel | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
SIGILON THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member | |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member | |
EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Stanford University | College/University | Masters Business Admin Doctorate Degree | |
Omnes Capital SAS
Omnes Capital SAS Investment ManagersFinance Omnes Capital SAS (Omnes Capital) is a private equity firm founded in 1984. The firm is headquartered in Paris, France with additional offices in Belgium, Switzerland, Germany. | Investment Managers | Private Equity Analyst Private Equity Investor | |
NOVARTIS AG | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Human Resources Officer Chief Tech/Sci/R&D Officer | |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
Fondation Santé | Director/Board Member Founder | ||
Tufts University School of Medicine | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
SOLID BIOSCIENCES INC. | Biotechnology | Chairman Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst General Counsel | |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistik
International
Vereinigte Staaten | 40 |
Frankreich | 5 |
Japan | 2 |
Irland | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 29 |
Consumer Services | 13 |
Finance | 7 |
Commercial Services | 2 |
Consumer Non-Durables | 2 |
Operativ
Director/Board Member | 421 |
Corporate Officer/Principal | 175 |
Independent Dir/Board Member | 99 |
Undergraduate Degree | 74 |
Chief Executive Officer | 66 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Anne-Sophie Herelle | 65 |
Douglas Cole | 44 |
George Scangos | 33 |
William Young | 32 |
Steven Holtzman | 28 |
Imad Toumi | 27 |
Adam Koppel | 26 |
Ian Smith | 24 |
Thomas Lynch | 20 |
Yuan Ding | 19 |
Roger Abravanel | 19 |
Joanne Viney | 18 |
B. Parshall | 17 |
John Cox | 15 |
Kevin Koch | 15 |
- Börse
- Insiders
- Fanny Cavalié
- Unternehmensverbindungen